Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Vickers
    Vickers
  2. Gonen
    Gonen
  3. Eastham
    Eastham
  4. D'Angelica
    D'Angelica
  5. Jarnagin
    Jarnagin
  6. Ehdaie
    Ehdaie
  7. Carlsson
    Carlsson
  8. Scardino
    Scardino
  9. Kingham
    Kingham
  10. Lilja
    Lilja

Groups

  1. Epidemiology and Biostatistics (685)
  2. Population Sciences Research Program (485)
  3. Surgery (392)
  4. Health Outcomes Research Group (365)
  5. Biostatistics Service (290)
  6. Urology (253)
  7. Survivorship Research (161)
  8. Center for Pancreatic Cancer Research (155)
  9. Department of Medicine (142)
  10. Sloan Kettering Institute Faculty (119)
Search Within
  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (516)
  2. Meeting Abstract (98)
  3. Editorial (28)
  4. Correspondence (27)
  5. Guidelines (6)
  6. Research Letter (5)
  7. Review (4)
  8. Conference Paper (1)
Groups
  1. Epidemiology and Biostatistics (685)
  2. Population Sciences Research Program (485)
  3. Surgery (392)
  4. Health Outcomes Research Group (365)
  5. Biostatistics Service (290)
  6. Urology (253)

More Groups

People
  1. Andrew Vickers (223)
  2. Mithat Gonen (94)
  3. James Eastham (67)
  4. Michael D'Angelica (65)
  5. Peter Scardino (63)
  6. William Jarnagin (63)

More People

Years
  1. 2025 (11)
  2. 2024 (44)
  3. 2023 (32)
  4. 2022 (47)
  5. 2021 (42)
  6. 2020 (43)

More Years

Publications
  1. European Urology (178)
  2. Journal of Urology (132)
  3. Journal of the American College of Surgeons (64)
  4. Urology (56)
  5. Annals of Thoracic Surgery (33)
  6. Lancet Oncology (29)

More Publications

Results (685)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Selecting patients with favorable risk, grade group 2 prostate cancer for active surveillance - Does magnetic resonance imaging have a role?
    Journal Article

    Stonier, T.; Tin, A. L.; Sjoberg, D. D.; Jibara, G.; Vickers, A. J.; Fine, S.; Eastham, J.
    Journal of Urology (2021)

    Fulltext@MSK | Save
  • Oncologic outcomes after localized prostate cancer treatment: Associations with pretreatment prostate magnetic resonance imaging findings
    Journal Article

    Wibmer, A. G.; Chaim, J.; Lakhman, Y.; Lefkowitz, R. A.; Nincevic, J.; Nikolovski, I.; Sala, E.; Gonen, M.; Carlsson, S. V.; Fine, S. W.; more...
    Journal of Urology (2021)

    Fulltext@MSK | Save
  • Hepatocellular carcinoma in patients with no identifiable risk factors
    Journal Article

    McIntyre, C. A.; Chou, J. F.; Gonen, M.; Shia, J.; Gambarin-Gelwan, M.; Balachandran, V. P.; Kingham, T. P.; Allen, P. J.; Drebin, J. A.; Jarnagin, W. R.; more...
    HPB (2021)

    Fulltext@MSK | Save
  • Problems with numbers in decision aids for prostate-specific antigen screening: A critical review
    Editorial

    Carlsson, S. V.; Vickers, A. J.; Gonsky, J. P.; Hay, J. L.; Hu, J. C.
    European Urology (2021)

    Fulltext@MSK | Save
  • Intraoperative ureteral stent use at radical cystectomy is associated with higher 30-day complication rates
    Journal Article

    Donat, S. M.; Tan, K. S.; Jibara, G.; Dalbagni, G.; Arslan Carlon, V.; Sandhu, J.
    Journal of Urology (2021)

    Fulltext@MSK | Save
  • Reply to Yi Sun, Fengxiang Sun, Qiang Wei, Jin Huang, and Ruiqi Duan's Letter to the Editor re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine use of magnetic resonance imaging for early detection of prostate cancer is not justified by the clinical trial evidence. Eur Urol 2020;78:304–6
    Correspondence

    Vickers, A.; Carlsson, S. V.; Cooperberg, M.
    European Urology (2021)

    Fulltext@MSK | Save
  • Temporal spatial heterogeneity of immune response to SARS-CoV-2 lung infection
    Meeting Abstract

    Desai, N.; Ting, D.; Neyaz, A.; Szabolcs, A.; Shih, A.; Chen, J.; Thapar, V.; Nieman, L.; Solovyov, A.; Mehta, A.; more...
    Journal of Molecular Diagnostics (2020)

    Fulltext@MSK | Save
  • Invasive central venous monitoring during hepatic resection: Unnecessary for most patients
    Journal Article

    O'Connor, D. C.; Seier, K.; Gonen, M.; McCormick, P. J.; Correa-Gallego, C.; Parker, B.; Weiser, E.; Balachandran, V. P.; Dematteo, R. P.; D'Angelica, M.; more...
    HPB (2020)

    Fulltext@MSK | Save
  • Re: Reconsidering prostate cancer mortality - The future of PSA screening: Against increasing PSA threshold to 10 ng/ml
    Correspondence

    Zlotta, A. R.; Carlsson, S. V.; Finelli, A.; Fleshner, N. E.
    European Urology (2020)

    Fulltext@MSK | Save
  • Fibroblast growth factor receptor 3 alteration status is associated with differential sensitivity to platinum-based chemotherapy in locally advanced and metastatic urothelial carcinoma
    Journal Article

    Teo, M. Y.; Mota, J. M.; Whiting, K. A.; Li, H. A.; Funt, S. A.; Lee, C. H.; Solit, D. B.; Al-Ahmadie, H.; Milowsky, M. I.; Balar, A. V.; more...
    European Urology (2020)

    Fulltext@MSK | Save